Intrapatient Dose Escalation of Anti–CTLA-4 Antibody in Patients With Metastatic Melanoma

類似資料

• Ipilimumab (Anti-CTLA4 Antibody) Causes Regression of Metastatic Renal Cell Cancer Associated With Enteritis and Hypophysitis
  著者:: Yang, James C., 等
  出版事項: (2007)
• Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma
  著者:: Royal, Richard E., 等
  出版事項: (2010)
• Tumor Regression and Autoimmunity in Patients Treated With Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Interleukin 2: A Phase I/II Study
  著者:: Maker, Ajay V., 等
  出版事項: (2005)
• Autoimmunity Correlates With Tumor Regression in Patients With Metastatic Melanoma Treated With Anti–Cytotoxic T-Lymphocyte Antigen-4
  著者:: Attia, Peter, 等
  出版事項: (2005)
• Cytotoxic T-Lymphocyte–Associated Antigen-4 Blockage Can Induce Autoimmune Hypophysitis in Patients With Metastatic Melanoma and Renal Cancer
  著者:: Blansfield, Joseph A., 等
  出版事項: (2005)